Literature DB >> 20818165

Impaired autophagy in Lafora disease.

Erwin Knecht1, Carmen Aguado, Sovan Sarkar, Viktor I Korolchuk, Olga Criado-García, Santiago Vernia, Patricia Boya, Pascual Sanz, Santiago Rodríguez de Córdoba, David C Rubinsztein.   

Abstract

Lafora disease (LD) is a progressive, lethal, autosomal recessive, neurodegenerative disorder that manifests with myoclonus epilepsy. LD is characterized by the presence of intracellular inclusion bodies called Lafora bodies (LB), in brain, spinal cord and other tissues. More than 50 percent of LD is caused by mutations in EPM2A that encodes laforin. Here we review our recent findings that revealed that laforin regulates autophagy. We consider how autophagy compromise may predispose to LB formation and neurodegeneration in LD, and discuss future investigations suggested by our data.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20818165      PMCID: PMC3039746          DOI: 10.4161/auto6.7.13308

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  1 in total

1.  Laforin, the most common protein mutated in Lafora disease, regulates autophagy.

Authors:  Carmen Aguado; Sovan Sarkar; Viktor I Korolchuk; Olga Criado; Santiago Vernia; Patricia Boya; Pascual Sanz; Santiago Rodríguez de Córdoba; Erwin Knecht; David C Rubinsztein
Journal:  Hum Mol Genet       Date:  2010-05-07       Impact factor: 6.150

  1 in total
  11 in total

1.  δ-Catenin engages the autophagy pathway to sculpt the developing dendritic arbor.

Authors:  Cheryl Ligon; Eunju Seong; Ethan J Schroeder; Nicholas W DeKorver; Li Yuan; Tammy R Chaudoin; Yu Cai; Shilpa Buch; Stephen J Bonasera; Jyothi Arikkath
Journal:  J Biol Chem       Date:  2020-06-17       Impact factor: 5.157

2.  Astrocytes and neurons produce distinct types of polyglucosan bodies in Lafora disease.

Authors:  Elisabet Augé; Carme Pelegrí; Gemma Manich; Itsaso Cabezón; Joan J Guinovart; Jordi Duran; Jordi Vilaplana
Journal:  Glia       Date:  2018-08-26       Impact factor: 7.452

Review 3.  Lafora disease.

Authors:  Julie Turnbull; Erica Tiberia; Pasquale Striano; Pierre Genton; Stirling Carpenter; Cameron A Ackerley; Berge A Minassian
Journal:  Epileptic Disord       Date:  2016-09-01       Impact factor: 1.819

Review 4.  Lafora disease: from genotype to phenotype.

Authors:  Rashmi Parihar; Anupama Rai; Subramaniam Ganesh
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

Review 5.  Neuroprotection in metabolism-based therapy.

Authors:  Adam L Hartman
Journal:  Epilepsy Res       Date:  2011-08-26       Impact factor: 3.045

6.  Erwin Knecht-the intelligent and mad, funny and grumpy man of autophagy.

Authors:  Erwin Knecht; Daniel J Klionsky
Journal:  Autophagy       Date:  2021-09-23       Impact factor: 13.391

7.  Muscle glycogen remodeling and glycogen phosphate metabolism following exhaustive exercise of wild type and laforin knockout mice.

Authors:  Jose M Irimia; Vincent S Tagliabracci; Catalina M Meyer; Dyann M Segvich; Anna A DePaoli-Roach; Peter J Roach
Journal:  J Biol Chem       Date:  2015-07-27       Impact factor: 5.157

8.  Impaired autophagy in neurons after disinhibition of mammalian target of rapamycin and its contribution to epileptogenesis.

Authors:  John McMahon; Xiaoxing Huang; Jun Yang; Masaaki Komatsu; Zhenyu Yue; Jiang Qian; Xinjun Zhu; Yunfei Huang
Journal:  J Neurosci       Date:  2012-11-07       Impact factor: 6.167

Review 9.  Does abnormal glycogen structure contribute to increased susceptibility to seizures in epilepsy?

Authors:  Mauro DiNuzzo; Silvia Mangia; Bruno Maraviglia; Federico Giove
Journal:  Metab Brain Dis       Date:  2014-03-19       Impact factor: 3.584

Review 10.  Beneficial Effects of Metformin on the Central Nervous System, with a Focus on Epilepsy and Lafora Disease.

Authors:  Pascual Sanz; José Maria Serratosa; Marina P Sánchez
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.